Online Program

Enhanced comprehensive HIV prevention planning (ECHPP) demonstration project: Experiences shifting to high impact prevention

Monday, November 4, 2013 : 4:30 p.m. - 4:50 p.m.

Stephen Flores, PhD, Prevention Research Branch, Centers for Disease Control and Prevention; Division of HIV/AIDS Prevention, Atlanta, GA
Blayne Cutler, MD, PhD, Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene, Queens, NY
Dara Geckeler, MPH, HIV Prevention Section, San Francisco Department of Public Health AIDS Office, San Francisco, CA
Tracey Packer, MPH, Community Health Equity & Promotion, San Francisco Department of Public Health, Population Health Division, San Francisco, CA
Coleman Terrell, AIDS Activity Coordinating Office, Philadelphia Department of Public Health, Philadelphia, PA
Holly Fisher, PhD, Deployment Risk Mitigation Unit, Centers for Disease Control and Prevention, Atlanta, GA
David W. Purcell, JD, PhD, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Issues: The US National HIV/AIDS Strategy (NHAS) sets out ambitious goals to reduce HIV infection by 2015. With many prevention budgets strained, increasing impact remains a challenge across jurisdictions. The Enhanced Comprehensive HIV Prevention Planning (ECHPP) project is a CDC-funded demonstration project aiming to prioritize prevention activities that maximize impact and accelerate scale-up of prevention efforts in 12 localities with the highest HIV burden in the US. A similar approach is now being funded by CDC for health departments across the country.

Description: This presentation will discuss strategies being used to support prioritizing prevention activities to increase HIV impact. After a brief overview of ECHPP, three health department grantees will present their decision making approach and describe successes and changes at local health systems to support these modified approaches to prevention. Case studies from the field will also describe strategies to increase impact of HIV prevention and care resources via sustainable structural changes, improved coordination among partners, and beneficial approaches to engaging communities.

Lessons Learned: This presentation will describe emerging promising practices that have been supportive to the ECHPP grantees during planning and implementation phases. They will cover decision making, strategic partnerships, policies to support HIV prevention, data use to improve service delivery, and strategies for coordination of an expanded HIV prevention portfolio.

Recommendations: Lessons learned from the implementation of ECHPP should be shared widely to other health departments implementing program activity in support of reaching the goals of the National HIV/AIDS Strategy

Learning Areas:

Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Program planning
Protection of the public in relation to communicable diseases including prevention or control
Public health or related public policy
Social and behavioral sciences

Learning Objectives:
Describe how ECHPP approached rapid implementation of NHAS and combination prevention strategies. Compare case studies from three participating health departments about implementing high impact prevention. Discuss with federal staff and health department staff participating in ECHPP about the implementation of high impact HIV prevention portfolios.

Keyword(s): HIV/AIDS, Prevention

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have worked in HIV prevention for the past 15 years as a Behavioral Scientist at the CDC. In this capacity, I have worked on randomized controlled trials, systematic literature reviews and large-scale demonstration projects all focused on HIV prevention. I have also worked on HIV prevention in Sub-Saharan Africa.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.